VHB-937

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameVHB-937
Drug Alias NameVHB-937VHB937
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTriggering receptor expressed on myeloid cells 2 stimulants
TargetsTriggering receptor expressed on myeloid cells 2
Therapy Area/IndicationsNeurodegenerative DiseasesAmyotrophic Lateral SclerosisAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[19] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNovartis Institutes For Biomedical Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Institutes For Biomedical Research IncNovartis Pharma AgNovartis Pharma Stein Ag +[4] 
Inactive CompaniesN/A
Active IndicationsNeurodegenerative DiseasesAmyotrophic Lateral SclerosisAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A